FDA Inspection 1072880 — Integrity Biosurgical Systems, Inc.
The FDA completed an inspection of Integrity Biosurgical Systems, Inc. on Nov 27, 2018 in Andover, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 27, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Andover, NJ (United States)